These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6443609)

  • 41. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
    Talaska G; Dooley KL; Kadlubar FF
    Carcinogenesis; 1990 Apr; 11(4):639-46. PubMed ID: 2323002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
    Randerath K; Miller RH; Mittal D; Randerath E
    IARC Sci Publ; 1988; (89):361-7. PubMed ID: 3198221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 32P-labeling test for DNA damage.
    Randerath K; Reddy MV; Gupta RC
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6126-9. PubMed ID: 7031643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of DNA modifications by the 32P-postlabelling assay.
    Phillips DH
    Mutat Res; 1997 Aug; 378(1-2):1-12. PubMed ID: 9288880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers.
    Phillips DH; Hemminki K; Alhonen A; Hewer A; Grover PL
    Mutat Res; 1988 Mar; 204(3):531-41. PubMed ID: 3347220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chemical carcinogens and DNA, covalent binding and chemical modifications].
    Dirheimer G
    Ann Biol Clin (Paris); 1986; 44(6):647-55. PubMed ID: 3826781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
    Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
    Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from 1'-hydroxy-2',3'-dehydroestragole: comparison of the adducts detected with the 1'-3H-labelled carcinogen and by 32P-postlabelling.
    Fennell TR; Juhl U; Miller EC; Miller JA
    Carcinogenesis; 1986 Nov; 7(11):1881-7. PubMed ID: 3769137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recoveries of DNA adducts of polycyclic aromatic hydrocarbons in the 32P-postlabelling assay.
    Segerbäck D; Vodicka P
    Carcinogenesis; 1993 Dec; 14(12):2463-9. PubMed ID: 8269613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved reversed-phase high-performance liquid chromatographic separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts of polycyclic aromatic hydrocarbons.
    Pfau W; Phillips DH
    J Chromatogr; 1991 Sep; 570(1):65-76. PubMed ID: 1797837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC; Earley K
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
    Randerath K; Haglund RE; Phillips DH; Reddy MV
    Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 32P-postlabelling analysis of DNA adducts from Fischer-344 rats administered 2,4-diaminotoluene.
    La DK; Froines JR
    Chem Biol Interact; 1992 Aug; 83(2):121-34. PubMed ID: 1505056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between diet and age-related DNA modifications (I-compounds) in rat liver and kidney.
    Li DH; Randerath K
    Cancer Res; 1990 Jul; 50(13):3991-6. PubMed ID: 2354447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzyme-mediated phosphorylation of polycyclic hydrocarbon metabolites: detection of non-adduct compounds in the 32P-postlabelling assay.
    Masento MS; Hewer A; Grover PL; Phillips DH
    Carcinogenesis; 1989 Aug; 10(8):1557-9. PubMed ID: 2665969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinogen-DNA adducts as tools in risk assessment.
    Airoldi L; Pastorelli R; Magagnotti C; Fanelli R
    Adv Exp Med Biol; 1999; 472():231-40. PubMed ID: 10736630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay.
    Reichert WL; Stein JE; French B; Goodwin P; Varanasi U
    Carcinogenesis; 1992 Aug; 13(8):1475-9. PubMed ID: 1499099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.